Great! :)
Thanks, we'll contact you soon.
Integrant and eMolecules: Streamlining Compound Sourcing and Retrosynthesis Planning
Integrant has strategically collaborated with eMolecules, integrating real-time chemical sourcing data into Integrant’s laboratory automation software. This partnership enables seamless access to essential chemical building blocks within the Integrant workflow, whether sourced from clients' proprietary libraries or directly from eMolecules' extensive library.
This integration significantly enhances Integrant’s cloud-based Retrosynthesis Module, empowering life sciences teams to efficiently plan and execute synthesis routes. By embedding live data directly into the retrosynthesis planning process, researchers can minimize manual tasks and avoid disruptions caused by switching between disconnected systems. With immediate access to over 50 million unique chemical structures and 76 million part numbers, scientists can now rapidly evaluate availability, pricing, and sourcing options, enabling quicker and more informed decisions.
Clients interested in activating the enhanced Retrosynthesis Module can easily connect with Integrant support for setup assistance. The embedded eMolecules API ensures continuous access to updated compound sourcing data directly within the familiar Integrant interface.
For both companies, this integration supports a mutual commitment to accelerating drug discovery timelines. Jeff Desroches, Senior Vice President of Corporate Development at eMolecules, shares, “At eMolecules, reducing drug discovery timelines is central to our mission. Our extensive offerings in chemical building blocks, screening compounds, and AI-driven automated synthesis help researchers identify and procure necessary compounds efficiently. Collaborating with Integrant aligns perfectly with our goal to streamline the drug discovery workflow, making the procurement process seamless and timely.”
Julie Pacheco, Vice President of Service at Integrant, adds, “Integrant focuses on efficiency and usability to empower researchers. By integrating eMolecules' real-time sourcing capabilities, we're eliminating unnecessary complexity and embedding sourcing directly into the retrosynthesis planning stage. This unified solution capitalizes on the strengths of both platforms, ultimately driving more impactful early discovery.”
Together, Integrant and eMolecules are reshaping the synthesis planning experience, creating a connected, intuitive, and researcher-focused approach from molecule design to laboratory execution.
Ready to streamline your retrosynthesis planning with Integrant and eMolecules?
